1-12 of 12
Benjamin G. Bitler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO043: Targeting beta-catenin and Wnt signaling in CTNNB1-mutated endometrial cancer

Marisa R. Moroney, Elizabeth R. Woodruff, Lubna Qamar, Benjamin G. Bitler, Bradley R. Corr
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (3_Supplement): PO043.
https://doi.org/10.1158/1557-3265.ENDOMET20-PO043
Published: 01 February 2021
View article titled, Abstract PO043: Targeting beta-catenin and Wnt signaling in <em>CTNNB1</em>-mutated endometrial cancer
Journal Articles

Abstract PO014: Clinicopathologic evaluation of CTNNB1 gene mutations in high-intermediate risk endometrial cancer

Jennifer G. Haag, Rebecca J. Wolsky, Marisa R. Moroney, Jamie Sheren, Jeanelle Sheeder, Benjamin G. Bitler, Bradley R. Corr
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (3_Supplement): PO014.
https://doi.org/10.1158/1557-3265.ENDOMET20-PO014
Published: 01 February 2021
View article titled, Abstract PO014: Clinicopathologic evaluation of <em>CTNNB1</em> gene mutations in high-intermediate risk endometrial cancer
Journal Articles

The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval

Kimberly R. Jordan, Matthew J. Sikora, Jill E. Slansky, Angela Minic, Jennifer K. Richer, Marisa R. Moroney, Junxiao Hu, Rebecca J. Wolsky, Zachary L. Watson, Tomomi M. Yamamoto, James C. Costello, Aaron Clauset, Kian Behbakht, T. Rajendra Kumar, Benjamin G. Bitler
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (23): 6362–6373.
https://doi.org/10.1158/1078-0432.CCR-20-1762
Published: 01 December 2020
View article titled, The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval
Open the PDF for The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval in another window
Includes: Supplementary data
Journal Articles

Abstract A30: Claudin-4-dependent mechanisms of high-grade serous ovarian cancer progression

Patricia Webb, Margaret C. Neville, Heidi Baumgartner-Wilson, Miriam D. Post, Andrew Goodspeed, Benjamin G. Bitler
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13_Supplement): A30.
https://doi.org/10.1158/1557-3265.OVCA19-A30
Published: 01 July 2020
View article titled, Abstract A30: Claudin-4-dependent mechanisms of high-grade serous ovarian cancer progression
Journal Articles

Abstract A77: Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma

Zachary L. Watson, Tomomi M. Yamamoto, Connor J. Hughes, Lindsay J. Wheeler, Miriam D. Post, Kian Behbakht, Benjamin G. Bitler
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13_Supplement): A77.
https://doi.org/10.1158/1557-3265.OVCA19-A77
Published: 01 July 2020
View article titled, Abstract A77: Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma
Journal Articles

Abstract A51: The role of ATF6-mediate AP-1 signaling in promoting PARP inhibitor-resistant ovarian cancer

Alexandra N. McMellen, Benjamin G. Bitler
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13_Supplement): A51.
https://doi.org/10.1158/1557-3265.OVCA19-A51
Published: 01 July 2020
View article titled, Abstract A51: The role of ATF6-mediate AP-1 signaling in promoting PARP inhibitor-resistant ovarian cancer
Journal Articles

Abstract GMM-058: CBX2 IDENTIFIED AS DRIVER OF ANOIKIS ESCAPE AND DISSEMINATION IN HIGH GRADE SEROUS OVARIAN CANCER

Lindsay J. Wheeler, Zachary L. Watson, Lubna Qamar, Alexandra McMellen, Tomomi Yamamoto, Kian Behbakht, Benjamin G. Bitler
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22_Supplement): GMM-058.
https://doi.org/10.1158/1557-3265.OVCASYMP18-GMM-058
Published: 15 November 2019
View article titled, Abstract GMM-058: CBX2 IDENTIFIED AS DRIVER OF ANOIKIS ESCAPE AND DISSEMINATION IN HIGH GRADE SEROUS OVARIAN CANCER
Journal Articles

Abstract NT-114: CATALYTIC SUBUNITS SWITCH DRIVES RESISTANCE TO EZH2 INHIBITORS IN ARID1A-MUTATED CELLS

Shuai Wu, Nail Fatkhutdinov, Takeshi Fukumoto, Benjamin G. Bitler, Pyoung Hwa Park, Andrew V. Kossenkov, Marco Trizzino, Alessandro Gardini, David W. Speicher, Rugang Zhang
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22_Supplement): NT-114.
https://doi.org/10.1158/1557-3265.OVCASYMP18-NT-114
Published: 15 November 2019
View article titled, Abstract NT-114: CATALYTIC SUBUNITS SWITCH DRIVES RESISTANCE TO EZH2 INHIBITORS IN ARID1A-MUTATED CELLS
Journal Articles

Abstract GMM-040: TARGETING WNT SIGNALING TO OVERCOME PARP INHIBITOR RESISTANCE

Tomomi M. Yamamoto, Alexandra McMellen, Zachary L. Watson, Jennifer Aguilera, Matthew J. Sikora, Rebecca Ferguson, Elmar Numammadov, George-Lucian Moldovan, Tanay Thakar, Hyunmin Kim, Diana M. Cittelly, Heidi Wilson, Kian Behbakht, Benjamin G. Bitler
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22_Supplement): GMM-040.
https://doi.org/10.1158/1557-3265.OVCASYMP18-GMM-040
Published: 15 November 2019
View article titled, Abstract GMM-040: TARGETING WNT SIGNALING TO OVERCOME PARP INHIBITOR RESISTANCE
Journal Articles

Abstract AP25: INHIBITION OF HDAC ACTIVITY SELECTIVELY INHIBITS ARID1A–MUTATED OVARIAN CLEAR CELL CARCINOMA THROUGH A NOVEL P53 REGULATORY MECHANISM

Benjamin G. Bitler, Pyoung Hwa Park, Yang Hai, Katherine M. Aird, Yemin Wang, David G. Huntsman, Kathleen R. Cho, David W. Christianson, Rugang Zhang
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11_Supplement): AP25.
https://doi.org/10.1158/1557-3265.OVCASYMP16-AP25
Published: 31 May 2017
View article titled, Abstract AP25: INHIBITION OF HDAC ACTIVITY SELECTIVELY INHIBITS ARID1A–MUTATED OVARIAN CLEAR CELL CARCINOMA THROUGH A NOVEL P53 REGULATORY MECHANISM
Journal Articles

Abstract AP31: TARGETING PD–L1/PD1 PATHWAY THROUGH BET PROTEIN INHIBITION IN EPITHELIAL OVARIAN CANCER

Hengrui Zhu, Fee Bengsch, Nikolaos Svoronos, Melanie R. Rutkowski, Benjamin G. Bitler, Michael J. Allegrezza, Yuhki Yokoyama, James E. Bradner, Jose R. Conejo-Garcia, Rugang Zhang
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11_Supplement): AP31.
https://doi.org/10.1158/1557-3265.OVCASYMP16-AP31
Published: 31 May 2017
View article titled, Abstract AP31: TARGETING PD–L1/PD1 PATHWAY THROUGH BET PROTEIN INHIBITION IN EPITHELIAL OVARIAN CANCER
Journal Articles

Intracellular MUC1 Peptides Inhibit Cancer Progression

Benjamin G. Bitler, Ina Menzl, Carmen L. Huerta, Barbara Sands, Wendy Knowlton, Andrew Chang, Joyce A. Schroeder
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (1): 100–109.
https://doi.org/10.1158/1078-0432.CCR-08-1745
Published: 31 December 2008
View article titled, Intracellular MUC1 Peptides Inhibit Cancer Progression
Open the PDF for Intracellular MUC1 Peptides Inhibit Cancer Progression in another window
Includes: Supplementary data